The 2 mg dose introduces GLP-1, GIP, and glucagon receptor stimulation at a level low enough that the body can adjust without significant disruption
A centralized tool simplifies logging doses, monitoring weight shifts, and analyzing body composition trends
While not naturally occurring as an isolated fragment, its parent protein contributes to gastrointestinal protection and repair
If you are experiencing significant side effects at 5mg, there is no reason to jump to 7.5mg at exactly the 4-week mark
GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications that mimic the action of naturally occurring GLP-1, an incretin hormone produced in the intestinal L-cells following food intake
For many patients, long-term use may be appropriate